Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Flow Cytometer Platform Improves High Throughput Screening

By LabMedica International staff writers
Posted on 17 May 2010
A fully automated platform has been introduced that combines cell-based screening and high throughput flow cytometry and efficiently incorporates analysis capabilities. More...
Potential applications include antibody screening, cytotoxicity studies, and biomarker analysis.

Flow cytometry (FC) is a technique for counting and examining cell suspensions by an electronic detection apparatus. This is one of the most sensitive methods for identifying fluorescent markers on cells and has now been integrated with proprietary technology and an advanced server-based informatics platform.

High Throughput Flow Cytometry (HTFC) Screening System uses HyperCyt, an automated sampler that transfers cells from microplate wells to the flow cytometer by means of peristaltic pump. The series of cells and air gaps are introduced into the cytometer in a highly controlled fashion. The data from each plate is stored in a single file and analyzed using HyperCytPRO, an advanced server based informatics platform. The simple, yet powerful apparatus allows for cost effective screening of more compounds, a broad range of experiments and analysis of complex data.

The HTFC screening system is produced by IntelliCyt Corporation (Albuquerque, NM, USA), which provides cell and bead-based screening products for life sciences and the pharmaceutical industry. The HTFC system can be used to differentiate cell populations or multiplexed bead suspensions from either 96-well or 384-well microplates at a rate of 40 wells per minute. A significant reduction in overall costs can be made as the apparatus can accommodate very small samples and minimal quantities of reagents.

R. Terry Dunlay, IntelliCyt president and CEO said, "By coupling our high-throughput sampler with the large dynamic range and multiplexing capability of flow cytometry-based detectors, the HTFC Screening System provides scientists with powerful advantages over other currently available technologies."

Related Links:
IntelliCyt Corporation



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.